People with MS who experience chronic lower body pain have altered gait patterns, walking more slowly than those without this symptom.| Multiple Sclerosis News Today
Ocrevus (ocrelizumab) is an infusion therapy approved to treat adults with relapsing forms of MS and primary progressive MS.| Multiple Sclerosis News Today
Ibudilast was shown on MRI scans to slow the growth of chronic active lesions in the brains of progressive MS patients in the SPRINT-MS trial.| Multiple Sclerosis News Today
The presence of two distinct chronic lesion markers on MRI is linked to faster disability progression in MS patients, researchers say.| Multiple Sclerosis News Today
A growing body of evidence has suggested EBV is a major environmental risk factor for MS. Learn more about its association with the disease.| Multiple Sclerosis News Today
In MS, slowly expanding lesions were linked to more myelin loss in brain regions of damage and in normal-appearing brain tissue, per a study.| Multiple Sclerosis News Today
Many people with MS experience heat intolerance. Triggers can include hot weather, increases in body temperature after exercise, or fever.| Multiple Sclerosis News Today
MRI is an imaging technique that can aid in diagnosing MS. Learn more about how this tool is used to detect MS and assess damage in the CNS.| Multiple Sclerosis News Today
Columnist Jennifer Powell describes her experience dealing with heat, which tends to worsen her MS symptoms.| Multiple Sclerosis News Today
MS is categorized into four main types: CIS, RRMS, SPMS, and PPMS. Learn more about each different type, their presentation, and treatment.| Multiple Sclerosis News Today
Abata Therapeutics has chosen its first treatment candidate for development: the T-cell therapy ABA-101 for certain forms of progressive MS.| Multiple Sclerosis News Today
Symptoms and early signs of MS vary from person to person. Common symptoms include movement problems, pain, fatigue, and vision problems.| Multiple Sclerosis News Today
Several tests, including MRI and blood tests, can be used to diagnose MS. Learn more about testing and what to expect after a diagnosis.| Multiple Sclerosis News Today
The exact causes of MS are not known, but several factors, such as genetic factors, infection, and demographics, are linked to MS development.| Multiple Sclerosis News Today
MS is not usually fatal, but it may increase the risk of life-threatening complications. Learn more about MS progression and life expectancy.| Multiple Sclerosis News Today
MS is defined by the presence of lesions in the nervous system. Learn more about MS lesions and view a picture of what brain lesions look like on an MRI.| Multiple Sclerosis News Today
While diet cannot replace treatment, studies suggest that a balanced diet may help patients to better manage and control multiple sclerosis.| Multiple Sclerosis News Today
Iaso Bio has received clearance from the FDA to start clinical trials to test its CAR T-cell therapy equecabtagene autoleucel in MS patients.| Multiple Sclerosis News Today
A $2.9 million research grant will fund a project aiming to advance a new technology to improve stem cell therapies for multiple sclerosis.| Multiple Sclerosis News Today
MS is an autoimmune disease that affects the central nervous system. Learn more about MS types, causes, symptoms, diagnosis, and treatment.| Multiple Sclerosis News Today